Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|September 11, 2025
Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case seriesJide Song, Hong Chang, Yi Lin, et al.
Respiratory Research|June 21, 2024
Correlation between immune-related adverse events and efficacy of PD-(L)1 inhibitors in small cell lung cancer: a multi-center retrospective studyJian Zhang, Aiqin Gao, Shuyun Wang, et al.
Frontiers in Pediatrics|September 22, 2025
A novel variant leads to WT1-related nephrotic syndrome and differences of sex development: a case reportShan Gao, Dahai Wang, Xingmei Ding, et al.
Water Research|January 17, 2026
Metabolic coupling of arsenic, carbon, nitrogen, sulfur and iron in high-salinity groundwater in the Yellow River Delta: Insights from metagenomic analysesChuanshun Zhi, Dahai Wang, Baonan He, et al.
HGG Advances|February 27, 2023
Biallelic pathogenic variants in the mitochondrial form of phosphoenolpyruvate carboxykinase cause peripheral neuropathyNeal Sondheimer, Alberto Aleman, Jessie Cameron, et al.
Frontiers in Pediatrics|December 9, 2024
Case Report: A rare pediatric case of paraneoplastic pemphigus associated with Castleman disease misdiagnosed as Behçets diseaseRanran Zhang, Jia Liu, Nana Nie, et al.
BMC Plant Biology|June 13, 2024
Comparative transcriptome analysis reveals genes involved in trichome development and metabolism in tobaccoMingli Chen, Zhiyuan Li, Xinxi He, et al.
Frontiers in Immunology|January 2, 2023
Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective studyDahai Wang, Chunrong Shan, Jia Liu, et al.
Biomed Research International|April 13, 2017
White Matter Integrity in Genetic High-Risk Individuals and First-Episode Schizophrenia Patients: Similarities and DisassociationsYifang Zhou, Jie Liu, Naomi Driesen, et al.
BMC Cancer|July 2, 2025
Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancerJian Zhang, Zijie Wu, Shuyun Wang, et al.
Pageof 9